27, 2020 (GLOBE NEWSWIRE) -- Metacrine, Inc., a clinical-stage biotechnology company focused on discovering and developing ... clinical professor of medicine at the University of Texas Health San Antonio and a principal ...
News
- Metacrine Presents Positive MET409 Phase 1b Clinical Data in NASH Patients at the Digital ...
- Texas given emergency exemption to use long-lasting antiviral product on American Airlines
Allied BioScience CEO Mike Ruley joined David Johnson on @KRLD's CEO Spotlight to discuss the @EPA's approval for the use of #SurfaceWise2 to ...
- Washington University spit test approved by FDA for virus
The St. Louis-area university worked with biotechnology company Fluidigm to develop the test, which allows people to collect their own testing ...
- Madrigal Pharma (MDGL) to Present Secondary Analyses of Data from Phase 2 NASH Study of ...
... Commonwealth University, Inova Campus and Affiliate Professor of Biomedical Sciences at George Mason University. ... University of Oxford, Oxford, England and Medical Director Pinnacle Clinical Research San Antonio, TX.
- Gene sleuths suggests wide virus spread from Boston meeting
... been linked to the gathering, an international meeting of executives of Biogen, a biotech company based in Cambridge, Massachusetts, in February.